Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Cancer Cytopathology, Wiley, Vol. 119, No. 5 ( 2011-10-25), p. 315-321
    Type of Medium: Online Resource
    ISSN: 1934-662X
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2011
    detail.hit.zdb_id: 2599218-1
    detail.hit.zdb_id: 2594979-2
    detail.hit.zdb_id: 1429-1
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 71, No. 8_Supplement ( 2011-04-15), p. 2271-2271
    Abstract: Background: Breast carcinomas (BCs) are more aggressive in African Americans (AAs) than in non-Hispanic Caucasian Americans (NHCAs); the reasons for this difference have not been fully elucidated. We recently demonstrated that single nucleotide polymorphisms (SNPs) at codon 72 of the p53 gene are significantly associated with a worse outcome in AAs with colorectal carcinomas. Therefore, we determined the prevalence of such SNPs in BCs and its possible association with adverse clinical or pathological features of BCs in AAs as well as NHCAs. Methods: To determine the phenotypic status at codon 72, DNA samples, extracted from 137 BCs and their matching benign tissues (from 47 AAs and 90 NHCAs), were analyzed for genotypes by direct sequencing of exon 4. Also, these samples were evaluated for microsatellite (MS) instability by use of the ABI 3100 system. The results obtained were correlated with the demographic and clinicopathological features of the BCs. Results: Overall, SNPs leading to either Arg/Pro or Pro/Pro at codon 72 were observed in 102 of 137 (74%) BCs, with a slightly higher prevalence in AAs compared to NHCAs (39 of 47; 83% vs. 63 of 90; 70%). The most frequent phenotype was Arg/Pro (84 of 137; 61%), followed by Arg/Arg (35 of 137; 26%) and Pro/Pro (18 of 137; 13%). The prevalence of the homozygous Pro/Pro phenotype, known to be associated with aggressive tumor behavior, was higher in AAs compared to NHCAs (19% vs. 10%). BCs with Pro/Pro or Arg/Pro SNPs were significantly more prevalent in grade III tumors (84%) than in grade I and II tumors (60%) (P=0.005); specifically, this distribution was highly significant in AAs (100% vs. 53%; χ2P=0.0001) as compared to NHCAs (72% vs. 62%; χ2P=0.451). Also, in AAs, BCs with the Pro/Pro phenotype were more frequently associated with MS stable status compared to the other phenotypes (63% vs. 18%; χ2P=0.011). Furthermore, Pro/Pro phenotype was associated with a shorter median survival in AAs (39.9 months) compared to NHCAs (112.2 months). Conclusions: These preliminary findings suggest that SNPs at codon 72 of p53 gene are associated with aggressive tumor behavior in AAs. Additionally, the Pro/Pro phenotype is associated with MS stable disease and with a shorter median survival in AAs but not in NHCAs. These studies were supported by the UAB-SPORE grant (a pilot study and a supplement) from NCI/NIH (5P50CA089019) and by the Susan G. Komen Breast Cancer Foundation (POP0601383). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2271. doi:10.1158/1538-7445.AM2011-2271
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    In: PLOS ONE, Public Library of Science (PLoS), Vol. 10, No. 6 ( 2015-6-12), p. e0129216-
    Type of Medium: Online Resource
    ISSN: 1932-6203
    Language: English
    Publisher: Public Library of Science (PLoS)
    Publication Date: 2015
    detail.hit.zdb_id: 2267670-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 71, No. 8_Supplement ( 2011-04-15), p. 2261-2261
    Abstract: Purpose: Several studies have examined the prognostic value of microsatellite instability (low, MSI-L, and high, MSI-H) phenotypes in colorectal adenocarcinomas (CRCs), but none have specifically considered patient race/ethnicity to assess the value of MSI-L. Therefore, this study assessed the prognostic value of the MSI-L phenotype in African-American and non-Hispanic Caucasian (NHCA) CRC patients separately. Experimental Design: CRCs from 276 African-Americans and 377 NHCAs, collected at the hospitals of the University of Alabama at Birmingham and Morehouse School of Medicine, were assessed for microsatellite instability and p53 mutational status (exons 4 through 9). MSI was assessed at 4 CA-dinucleotide MS loci (Mfd 27, Mfd 41, Mfd 47, and Mfd 57) and 2 poly-A repeats (BAT25, BAT26). Samples were considered MSI-H if at least 2 loci showed instability and MSI-L (low) if only 1 marker was unstable. The phenotypes were correlated with clinicopathologic features and patient survival by use of the χ2 test and univariate Kaplan-Meier analyses, respectively. Results: The incidence of the MSI-L phenotype was higher in African-American patients (49 of 276, 18%) compared to NHCA patients (27 of 377, 7%). In contrast, the frequency of the microsatellite stable (MSS) phenotype was higher in CRCs of NHCAs (72%) than in CRCs of African-Americans (56%). In addition, the incidence of microsatellite instability-high (MSI-H) phenotype was similar in African-Americans (26%) and NHCAs (21%). Presence of the MSI-L phenotype significantly correlated with a higher incidence of missense p53 mutations (64%) and high-grade tumors (31%) and with advanced stages (III and IV) (67%) of CRCs in NHCAs. Such associations, however, were not found in African-American patients. For NHCA patients, CRCs with the MSI-L phenotype had significantly higher mortality (log-rank p=0.044) as compared to MSS or MSI-H. In contrast, for African-American patients, the MSI-L phenotype was associated with a better prognosis (log-rank p=0.043) compared to the MSS or MSI-H phenotypes. Conclusions: These findings suggest that CRC with the MSI-L phenotype is associated with p53 mutations, high-grade tumors, and advanced tumor stage, and with short survival of NHCAs but not African-Americans. This work was supported by grants from the NCI/NIH (2U54-CA118948-03, R01-CA98932, and R03-CA139629). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2261. doi:10.1158/1538-7445.AM2011-2261
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 5
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2011
    In:  Cancer Research Vol. 71, No. 8_Supplement ( 2011-04-15), p. 1167-1167
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 71, No. 8_Supplement ( 2011-04-15), p. 1167-1167
    Abstract: Background: MicroRNAs (miRNAs) have potential prognostic and therapeutic value in human malignancies, including colorectal cancer (CRC). Many human tumor tissues are available as formalin-fixed paraffin-embedded (FFPE) specimens, which are an excellent source for biomarker discovery. However, the stability of miRNAs and the reliability of measurements of miRNA expression in archival samples stored for long periods of time ( & gt; 20 years) are not known. Therefore, we evaluated the stability and expression levels of miRNAs in FFPE CRC specimens and compared their expression levels to those in CRC cell lines. Methods: A panel of seven miRNAs (RNU6B, miR-20a, miR-21, miR-106a, miR-181b, miR-203, and miR-324-5p) in 219 CRC archival tissue samples, stored for 6 to 28 years (1982 through 2004) in a dark, cool place, and 11 CRC cell lines (LoVo, HCT116, HCT116 (p53-/-), RKO, LS174T, CaCo-2, Colo205, SW480, WiDr, HCT-15, and DLD-1) were evaluated by the use of TaqMan® microRNA assays and by quantitative real-time polymerase chain reactions. In CRCs, these miRNAs, excluding RNU6B (an endogenous reference molecule), are candidate prognostic or predictive biomarkers. All assay reagents used were from Applied Biosystems Inc., (Carlsbad, CA). From each block, tissue sections, 10-microns thick, were used for extraction of miRNAs. miRNA expression was measured as threshold cycle (Ct) values. Triplicate reactions were averaged for each miRNA, and the raw Ct values were determined. The Kruskal-Wallis one-way analysis of variance was employed to analyze the miRNA expression difference among archived samples from different years. Correlation coefficient analysis was performed to compare the expression levels of miRNA in archival tissues and cell lines. Results: In both CRC archival tissues and cell lines, the median Ct values of all miRNAs ranged from 19 to 32. All seven miRNAs were stable in CRC tissues stored for up to 28 years; their expression levels were similar across all ages of blocks. (Kruskall-Wallis P values for all 7 miRNAs ranged from 0.627 to 1.000.) There was good correlation between the levels of expression of all seven miRNAs in FFPE tissues and in the CRC cell lines (correlation coefficient R2 range, 0.784 to 0.937). Conclusions: Since miRNAs are stable in archival CRC samples stored for over 20 years, FFPE samples can be used to evaluate miRNAs as biomarkers. These studies were supported by grants 2U54-CA118948-03, R01-CA98932, and R03-CA139629 from the NCI/NIH. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1167. doi:10.1158/1538-7445.AM2011-1167
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2011
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 6
    Online Resource
    Online Resource
    American Association for Cancer Research (AACR) ; 2010
    In:  Cancer Research Vol. 70, No. 8_Supplement ( 2010-04-15), p. 4647-4647
    In: Cancer Research, American Association for Cancer Research (AACR), Vol. 70, No. 8_Supplement ( 2010-04-15), p. 4647-4647
    Abstract: Background: The Rabphillin-3A-like (RPH3AL) gene, located at the 17p13.3 locus, has been reported to be involved in progression and metastasis of colorectal cancer. Since there have been no studies of this gene in breast cancer (BC), mutations and loss of heterozygosity (LOH) of RPH3AL in BCs were evaluated. Methods: BCs (n=104) and matching benign tissues were evaluated for LOH by use of two locus-specific polymorphic markers (D17S1866 and D17S643) and ABI-3100 sequencing technology. Of 104 cases, 16 had corresponding snap-frozen BCs and benign epithelial tissues. The cDNA samples of these frozen cases were analyzed for RPH3AL mutations by RT-PCR and direct sequencing. Since most of the missense mutations were located in the exon-6 region, the genomic DNA samples of 68 (of 104) BCs and their corresponding benign tissues were assessed only for exon 6 by the use of exon-6 specific primers. Additionally, 96 (of 104) BCs and the corresponding control tissues were analyzed for germ line mutations at 43 base pairs downstream from exon-6. Mutations and LOH status were correlated with clinicopathologic features of BCs and patient overall survival by chi-square and Kaplan-Meier analyses, respectively. Results: LOH analysis demonstrated that 69 of 99 (70%) informative cases exhibited LOH in at least one marker. In total, 19% (13 of 68) of BCs exhibited missense point mutations in the coding region (exon-6) of RPH3AL. Six BCs exhibited mutations at codon 175, two BCs at codon 200, one BC had double mutations at codon 178 and 189, and four BCs had single mutations at codons 165, 174, 181 and 196. There was a germ-line mutation (G & gt;T) at 43 base pairs downstream from exon-6. Genotyping of this alteration showed that 31% (30 of 96) of BCs were homozygous for the G/G allele, 56% (54 of 96) were heterozygous for G/T, and 13% (12 of 96) were homozygous for T/T. In our correlative analysis, most BCs with mutations were associated with lymph-node metastases (9 of 13, 69%) and with an allelic loss (8 of 13, 62%). The G/G alleles were more commonly found in African-Americans than Caucasians (χ2, p=0.003), in ER/PR positive BCs than in ER/PR negative BCs (χ2, p=0.03), and in BCs with advanced stage (χ2, p=0.02). The incidence of LOH increased with nodal metastasis (χ2, p=0.04) and tumor size (χ2, p=0.05) of the BCs. Furthermore, LOH was significantly associated with poor patient survival (log rank, p=0.002). Conclusions: The results suggest that genetic alterations in the RPH3AL gene are associated with aggressive behavior of breast cancer. (Grant Support: UAB-Breast SPORE-Pilot and Susan G. Komen Breast Cancer Foundation, POP138306). Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4647.
    Type of Medium: Online Resource
    ISSN: 0008-5472 , 1538-7445
    RVK:
    RVK:
    Language: English
    Publisher: American Association for Cancer Research (AACR)
    Publication Date: 2010
    detail.hit.zdb_id: 2036785-5
    detail.hit.zdb_id: 1432-1
    detail.hit.zdb_id: 410466-3
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. Further information can be found on the KOBV privacy pages